Charleston, SC -- (SBWIRE) -- 08/20/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: Writer s Group Film Corp (OTCMKTS:WRIT), Epazz Inc (OTCMKTS:EPAZ), Generex Biotechnology Corporation (OTCMKTS:GNBT), Amarium Technologies Inc. (OTCMKTS:AMMG)
Writer s Group Film Corp (OTCMKTS:WRIT) moved -25.00 percent lower at $0.0006.So far, around 78.27 million shares has changed hands in this session. After opening at $0.0008, the stock hit as high as $0.0008. However, it traded between $0.0002 and$0.006 over the last twelve months. Writers’ Group Film Corp. is an entertainment production company, specializing in film, television and Web-based entertainment products. The Company owns one completed short film, The G! True Tinseltown Tale: Dude, Where’s My Car?, a fictional behind-the-scenes-style mockumentary about the making of the 2000 film, Dude, Where’s My Car?, which satirizes both that film, as well as the television show The E! True Hollywood Story.
Has WRIT Found The Bottom and Ready To Move Up? Find Out Here
Epazz Inc (OTCMKTS:EPAZ) was at $0.0011, showing a -21.43% decrease. Around 7.10 million shares have been traded, versus an-average trading volume of 21.40 million shares. The company is now valued at around $3.73 million. EPAZZ, Inc. is a holding company. The Company develops a Web portal infrastructure operating system product called BoxesOS v3.0. The Company offers seven primary product lines. The Epazz BoxesOS v3.0 product is offered through Epazz, Inc., the Desk/Flex Software product is offered through Desk Flex, Inc., the Agent Power product is offered through Professional Resource Management.
Has EPAZ Found The Bottom And Ready To Gain Momentum? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) moved 2.56 percent higher at $0.0360 and is trading between $0.03 and $0.04 after opening the day at $0.04. Its performance over the last five days remained -5.26%, which stands at -7.69% for a month. Going back further than one month, 1-year performance after recent close was 44%. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Will GNBT Continue To Move Higher? Find Out Here
Amarium Technologies Inc. (OTCMKTS:AMMG) shares rose today, gaining 2.19 percent to $0.280. The stock is up around 30.95% in 2013 and 63.89% for the last 12 months. Around 385,716.00 shares changed hands so far in this session compared to an-average trading volume of 40,344.00 shares. Amarium Technologies Inc., formerly Cirond Corporation, develops software solutions, and provides network security products and consulting services to governments and private sector businesses to combat the threat to wired networks from unauthorized wireless networks.
Why Should Investors Buy AMMG After The Recent Gain? Just Go Here and Find Out
About Impressive Penny Stocks:
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)